Metraipolis › archive › dc_062d3dbb1c4e

The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy — Europe PMC PMID:42211521

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42211521
DOI
10.3389/fonc.2026.1843273
License (as archived)
solo-consultazione
Archived
2026-11-02T07:35:17.413Z
SHA-256 of the archived text
ea701e515c89df265db9eaa94c3e0f851528a1f8dbe291284a3bf33a7ac7b300
Stable URL of this page
https://metraipolis.com/documento/dc_062d3dbb1c4e

How to cite

The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy — Europe PMC PMID:42211521 — Europe PMC (en), https://europepmc.org/article/MED/42211521 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_062d3dbb1c4e (Metraipolis archive dc_062d3dbb1c4e, sha256 ea701e515c89df265db9eaa94c3e0f851528a1f8dbe291284a3bf33a7ac7b300)
BibTeX
@misc{dc062d3dbb1c4e,
  title = {The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy — Europe PMC PMID:42211521},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42211521},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_062d3dbb1c4e; sha256 ea701e515c89df265db9eaa94c3e0f851528a1f8dbe291284a3bf33a7ac7b300},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42211521. Agents can read the archived copy with the MCP tool read_document.